- Home
- NSA vs DNLI Comparison
NSA vs DNLI Comparison
Compare NSA & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSA | DNLI |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | 1458 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | NSA | DNLI |
|---|---|---|
| Price | $42.92 | $21.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $34.38 | $34.33 |
| AVG Volume (30 Days) | 721.5K | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.39 | $408.85 |
| P/E Ratio | $56.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.43 | $12.58 |
| 52 Week High | $44.02 | $23.77 |
Technical Indicators
Market Signals| Indicator | NSA | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 61.34 |
| Support Level | $40.89 | $17.99 |
| Resistance Level | $43.96 | $22.07 |
| Average True Range (ATR) | 0.84 | 0.90 |
| MACD | -0.06 | 0.25 |
| Stochastic Oscillator | 68.64 | 96.25 |
Price Performance
Historical ComparisonAbout NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.